SIX · SIX Healthcare NOVN
Novartis dividend history
NOVN · Novartis
CHF 95.00 ▼ CHF 0.92 · -0.96%
Market open · 15:26 local Jun 26, 2026 Prices delayed ≥15 min Sample data
Price chart
…
Key statistics
Market cap
CHF 190.00B
P/E (TTM)
13.0×
EPS (TTM)
CHF 7.31
Dividend yield
2.79%
52-week range
CHF 68.64 – CHF 95.92
Avg volume
5.7M
Beta
1.29
Prev close
CHF 95.92
About Novartis
AI-assisted summaryNovartis (NOVN) is a company listed on SIX in the Healthcare sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.
Dividend history
Annual payout (TTM): CHF 2.65 · Forward yield: 2.79%| Ex-date | Pay date | Amount | Frequency | Dividend yield |
|---|---|---|---|---|
| Jun 21, 2026 | Jun 28, 2026 | CHF 2.65 | Annual | 2.79% |
| Jun 21, 2025 | Jun 28, 2025 | CHF 2.58 | Annual | 2.72% |
| Jun 21, 2024 | Jun 28, 2024 | CHF 2.60 | Annual | 2.74% |
Financials
Annual figures, last 5 fiscal years.
| Date | Revenue | Net income | EPS (TTM) | P/E (TTM) |
|---|---|---|---|---|
| FY2024 | CHF 99.95B | CHF 20.34B | CHF 5.69 | 14.5× |
| FY2023 | CHF 86.79B | CHF 13.21B | CHF 6.27 | 11.9× |
| FY2022 | CHF 79.71B | CHF 10.46B | CHF 6.37 | 12.4× |
| FY2021 | CHF 73.09B | CHF 9.84B | CHF 6.94 | 14.5× |
| FY2020 | CHF 61.64B | CHF 4.92B | CHF 7.60 | 13.0× |
Stock splits
No stock splits on record for Novartis.
Analyst forecast
12-month price target
CHF 91.07
Consensus rating
Sell
Implied upside
-4.14%
Based on 12 analysts
12-month
Aggregated analyst estimates (sample)
Related
Frequently asked questions
What is the current Novartis share price?
Novartis (NOVN) last traded at CHF 95.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.
Does Novartis pay a dividend?
Yes — Novartis has a forward dividend yield of about 2.79%, based on its trailing 12-month payout.
What is Novartis's market capitalisation?
Novartis has an approximate market capitalisation of CHF 190.00B.
What is Novartis's P/E ratio?
Novartis trades at a trailing P/E ratio of about 13.0.